Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 10Colorectal Neoplasms 5Ovarian Neoplasms 4Endometrial Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Prostatic Neoplasms 3Rectal Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Wilms Tumor 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neurofibromatosis 1 1Neoplastic Syndromes, Hereditary 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lipodystrophy, Familial Partial 1Leukemia, Myeloid, Acute 1Histiocytosis, Non-Langerhans-Cell 1Histiocytosis, Langerhans-Cell 1Hepatic Veno-Occlusive Disease 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

plerixafor 1Specimen Handling 1Radiotherapy 1Oxycodone 1Ondansetron 1Music Therapy 1Morphine 1Methadone 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Genetic Counseling 1Follow-Up Studies 1Fluorescent Antibody Technique 1Chromatin Immunoprecipitation Sequencing 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoproliferative Disorders × Genetic Testing × Clear all
NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic

Phase NA Recruiting
82 enrolled
LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡